Question Bank › Forward agenda is conversion work

Forward agenda is conversion work

Forward agenda is conversion work: management's own stated priorities are about turning already-secured growth into resu

Calls Tested
430
Answered YES
54
Hit Rate
12.6%
rare by design

DexCom, Inc. (DXCM) — this company's answers

NO on the Q4 2023 call 2024-02-08 B+
The model's full reasoning — Q4 2023 call → NO我们根据提供的财报电话会议记录来判断。管理层在电话中讨论的未来议程是否主要是将已获得的增长转化为交付结果,并且这些已获得的增长尚未在报告的数字中体现。 首先,看第一点:前瞻议程是转化工作而非追求工作。管理层提到: - 马来西亚工厂已开业并正在提升产量。 - G7已推出,正在扩大覆盖。 - Stelo即将推出,但尚未上市。 - 销售团队正在扩大,以覆盖更多医生。 - 15天传感器正在开发中。 这些工作很多是执行已启动的项目,比如扩大销售团队以服务已获得的覆盖范围,或者将G7推广到更多市场。但Stelo是新产品,尚未获得批准,属于追求新市场。然而,管理层明确表示Stelo的推出是学习过程,且已提交FDA,属于已承诺的路径。 第二点:已获得的增长是否仍大部分在数字之前?管理层提到2023年增长强劲,但2024年指引增长16-21%,其中包含Stelo的贡献。但管理层也提到,G7的转换正在进行,且基础用户仍在G6上,这会影响毛利率。但整体上,管理层没有明确说已获得的增长尚未反映在数字中,而是说增长正在发生。 关键点:管理层在回答中多次提到“我们正在扩大销售队伍”、“我们正在投资”、“我们正在推出Stelo”,这些是前瞻性工作,但并非全部是转化已获得的业务。例如,Stelo是新产品,需要获得市场接受,属于追求新需求。而扩大销售队伍是为了覆盖更多医生,这更多是追求新客户,而非转化已签约客户。 此外,管理层提到“我们正在将G7推广到更多市场”,这属于执行已推出的产品,但市场扩展本身是追求新需求。 因此,前瞻议程中既有转化工作(如扩大销售队伍以服务已覆盖的医生),也有追求工作(如Stelo新市场)。但管理层没有明确表示已获得的增长尚未反映在数字中,而是说增长正在加速。 根据指令,需要两个条件都满足才回答YES。这里似乎不满足第二点,因为管理层没有明确说已获得的增长尚未体现在结果中,而是说增长正在发生。 因此,答案应为NO。

← Back to the full DXCM analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, when management describes what the company is focused on over the coming quarters — its own stated priorities, tasks, and to-do list — is that forward agenda substantially about CONVERTING GROWTH THE COMPANY HAS ALREADY SECURED into delivered results, AND does management convey that the reported results do not yet meaningfully reflect that secured growth? Answer YES when BOTH halves come through in management's own words, in whatever form fits the business: (1) THE FORWARD AGENDA IS CONVERSION WORK, NOT PURSUIT WORK. When management talks about what it is doing next — in prepared remarks, in answers, or both — a clear and substantial part of that agenda consists of executing on business that already exists or is already committed: delivering or fulfilling orders, contracts, awards, or programs already won; ramping, opening, commissioning, or loading a facility, capacity, product, location, or capability already built or recently launched; onboarding, installing, enrolling, or scaling customers or partners already signed; hiring, training, producing, stocking, or sequencing specifically to serve identified business already in hand or already arriving. The work may take whatever form fits the industry. What matters is the direction of management's stated effort: the demand side of this growth is treated as settled, and management's described job is turning it into delivered business. (2) THE SECURED GROWTH IS STILL MOSTLY AHEAD OF THE NUMBERS. Management conveys, directly or plainly in substance, that this already-secured business has contributed little of its expected effect to the results being reported — its revenue, volume, or contribution is early, ramping, scheduled, or still to come — so the just-reported numbers describe a smaller business than the one management is already working to deliver, and management treats the difference as meaningful to the company's trajectory rather than trivial. Answer NO if management's forward agenda is chiefly about winning demand, improving market conditions, pipeline conversion, competitive positioning, or hoped-for opportunities not yet committed. NO if the secured business is routine, ordinary-course volume for this company that management does not present as changing its level of business. NO if the committed growth is already substantially reflected in the reported results. NO if the forward work depends on approvals, financing, negotiations, or counterparty decisions not yet obtained. NO if management is chiefly explaining delays, cancellations, or problems with previously secured business. NO if the agenda is mainly cost cutting, restructuring, turnaround repair, or defending weak results. NO if the conversion story appears only in an analyst's question or model that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
ERO Ero Copper Corp. Q1 2024 2024-05-10 A
AZEK The AZEK Company Inc. Q2 2024 2024-05-08 B+
AES The AES Corporation Q1 2024 2024-05-03 C+
ROCK Gibraltar Industries, Inc. Q1 2024 2024-05-01 B+
DUOT Duos Technologies Group, Inc. Q4 2023 2024-04-01 F
KOPN Kopin Corporation Q4 2023 2024-03-14 C+
GIII G-III Apparel Group, Ltd. Q4 2024 2024-03-14 C
BRBR BellRing Brands, Inc. Q4 2023 2023-11-21 B+
EFXT Enerflex Ltd. Q3 2023 2023-11-09 C+
PTLO Portillo's Inc. Q2 2023 2023-08-05 B
GVP GSE Systems, Inc. Q1 2023 2023-05-15 D
CDE Coeur Mining, Inc. Q1 2023 2023-05-11 C+
KE Kimball Electronics, Inc. Q3 2023 2023-05-06 C+
BRX Brixmor Property Group Inc. Q1 2023 2023-05-02 A
TACT TransAct Technologies Incorporated Q4 2022 2023-03-08 A
ESEA Euroseas Ltd. Q4 2022 2023-02-15 C+
PI Impinj, Inc. Q4 2022 2023-02-08 B+
CEIX CONSOL Energy Inc. Q4 2022 2023-02-07 B
PKOH Park-Ohio Holdings Corp. Q3 2022 2022-11-13 B
FLL Full House Resorts, Inc. Q3 2022 2022-11-07 B
MEC Mayville Engineering Company, Inc. Q3 2022 2022-11-05 B+
EVGO EVgo, Inc. Q2 2022 2022-08-09 C+
CRL Charles River Laboratories International Q2 2022 2022-08-03 C
SYM Symbotic Inc. Q3 2022 2022-08-01 B+
OGI OrganiGram Holdings Inc. Q3 2022 2022-07-14 B+
VNRX VolitionRx Limited Q1 2022 2022-05-12 F
BXP Boston Properties, Inc. Q1 2022 2022-05-03 A
FAT FAT Brands Inc. Q4 2021 2022-03-21 F
FLUX Flux Power Holdings, Inc. Q2 2022 2022-02-10 D
GTES Gates Industrial Corporation plc Q4 2021 2022-02-07 C+
GFS GLOBALFOUNDRIES Inc. Q3 2021 2021-11-30 A
RNW ReNew Energy Global Plc Q2 2022 2021-11-18 C
BFI BurgerFi International, Inc. Q3 2021 2021-11-12 C
HY Hyster-Yale Materials Handling, Inc. Q3 2021 2021-11-06 D
OWL Blue Owl Capital Inc. Q2 2021 2021-08-10 B+
ALB Albemarle Corporation Q3 2018 2018-11-08 B
KOP Koppers Holdings Inc. Q2 2018 2018-08-12 C+
PRIM Primoris Services Corporation Q2 2018 2018-08-11 C+
XOM Exxon Mobil Corporation Q2 2018 2018-07-27 C
KIM Kimco Realty Corporation Q2 2018 2018-07-26 B+
MKC McCormick & Company, Incorporated Q2 2018 2018-06-28 C+
ACHC Acadia Healthcare Company, Inc. Q4 2017 2018-02-22 C+
SBSI Southside Bancshares, Inc. Q4 2017 2018-02-06 A
CPK Chesapeake Utilities Corporation Q3 2017 2017-11-10 A
GNTX Gentex Corporation Q3 2017 2017-10-20 B
LIND Lindblad Expeditions Holdings, Inc. Q2 2017 2017-08-06 C
FLEX Flex Ltd. Q1 2018 2017-07-28 F
BP BP p.l.c. Q4 2016 2017-02-07 B+
ARAY Accuray Incorporated Q4 2016 2016-08-17 B
GOGO Gogo Inc. Q1 2016 2016-05-06 C+
ESE ESCO Technologies Inc. Q2 2016 2016-05-03 A
RCL Royal Caribbean Cruises Ltd. Q1 2016 2016-04-29 C+
HPP Hudson Pacific Properties, Inc. Q4 2015 2016-02-25 C
HXL Hexcel Corporation Q4 2015 2016-01-22 B+

How the model reasoned

EVGO · Q2 2022 → YESThe question is about whether management's forward agenda is about converting already secured growth into results, and if the reported results don't yet reflect that growth. YES The forward agenda centers on converting already-secured growth: the Pilot-GM eXtend deal (up to 2,000 stalls + 500 locations) is described as recently announced and exceeding IRR hurdles, with EVgo procuring, constructing, operating, and maintaining the assets on a capital-light basis; the 2022 guidance is affirmed and tracked, with heavier second-half loads explicitly tied to PFJ and fleet contractual revenues kicking in Q3/Q4 (some already baked into forecasts after late-2021 negotiations); current stall counts (2,397 in operation/under construction, 3,669 pipeline) and throughput explicitly exclude the 2,000-stall Pilot contribution; Delta supply agreement covers the first phase of the PFJ deal through 2026; and execution themes include ramping stalls, commissioning, fleet onboarding, and regulatory credit recognition tied to these committed contracts. The reported Q2 results ($9.1M revenue, 10.
BRBR · Q4 2023 → YESThe question is: On this call, when management describes what the company is focused on over the coming quarters — its own stated priorities, tasks, and to-do list — is that forward agenda substantial...YES The forward agenda centers on converting already-secured growth by ramping production (17% growth in fiscal '23, 20%+ planned for '24 via new co-mans and Michael Foods startup in December), restarting promotions and marketing once supply allows, and scaling the transformed co-man network to fulfill committed demand — all while noting tight supply dynamics persisting through most of fiscal '24. Management explicitly conveys that the reported FY '23 results (22% sales growth, 25% EBITDA growth) reflect only a portion of the secured trajectory, with the bulk of new capacity contributions and promotional lift still ahead in fiscal '24, treating 10-15% sales and 6-15% EBITDA guidance as the meaningful next step rather than a routine continuation.
EFXT · Q3 2023 → YESThe question is: Does management describe their focus over coming quarters as converting already secured growth into delivered results, AND do they convey that reported results don't yet meaningfully ...YES The transcript shows management's forward agenda centers on converting secured growth: executing on the $1.6 billion Engineered Systems backlog for 2024 revenue visibility, realizing remaining USD 60 million synergies from Exterran integration, consolidating facilities, and prioritizing debt reduction plus operational efficiency. They describe this as turning already-committed 2024 activity into delivered results, with the backlog providing "strong visibility into revenue generation and business activity levels for 2024" and embedded margins in line with mid-teens targets.

More from the question bank

Running hot in customers' handsBigger than they can carry aloneSecond proving already underwayOvertaken by their own successDoors opening at the company's own gatesAnswers go deeper than the scriptAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.